Taiwan FDA registration ab61079d2d7407e1306e335e5e3e0974
Baynex Respiratory Fusion Viral Antigen Rapid Test Reagent
TW: 拜奈克思呼吸道融合病毒抗原快速檢驗試劑
Taiwan·Risk Class 1·BINAX, INC·Registered Oct 24, 2005 – Oct 24, 2010CancelledRegistration details
- Analysis ID
- ab61079d2d7407e1306e335e5e3e0974
- Customs Code
- DHA04400117303
Company information
- Manufacturer
- BINAX, INC
- Manufacturer Country
- United States
- Authorized Representative
- Dachen Biotechnology Co., Ltd
Product details
- Intended Use
- It is used in serum tests to identify antibodies to respiratory fusion cell viruses in serum.
- Product Type (Level 1)
- C Immunology and microbiology
- Import Information
- import
Dates and status
- Registration Date
- Oct 24, 2005
- Expiry Date
- Oct 24, 2010
- Cancellation Date
- Nov 06, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Baynex Respiratory Fusion Viral Antigen Rapid Test Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number ab61079d2d7407e1306e335e5e3e0974 and manufactured by BINAX, INC. The authorized representative in Taiwan is Dachen Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices